Biocon Biologics Overview

  • Year Founded
  • 1978

Year Founded

  • Status
  • Private

  • Employees
  • 9,500

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 11

  • Investments
  • 3

Biocon Biologics General Information

Description

Developer of biosimilars intended to expand patient access to a better class of therapies across the world. The company engages in the development, manufacturing and commercialization of biosimilars, including recombinant human insulin (rh-insulin), insulin analogs, monoclonal antibodies and therapeutic proteins for oncology, immunology or other chronic disease areas.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Corporate Office
  • Biocon House, Semicon Park
  • Electronics City, Phase-II, Hosur Road
  • Bengaluru, Karnataka 560100
  • India
+91 080677
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • Biocon House, Semicon Park
  • Electronics City, Phase-II, Hosur Road
  • Bengaluru, Karnataka 560100
  • India
+91 080677

Biocon Biologics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biocon Biologics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biocon Biologics‘s full profile, request access.

Request a free trial

Biocon Biologics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biocon Biologics Investments (3)

Biocon Biologics’s most recent deal was a Buyout/LBO with Hulio. The deal was made on 23-Dec-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Hulio 23-Dec-2025 Buyout/LBO Buildings and Property
Viatris (Biosimilar Business) 29-Nov-2022 Buyout/LBO Drug Discovery
Pfizer (R&D facility) 24-Sep-2019 Corporate Asset Purchase Buildings and Property
To view Biocon Biologics’s complete investments history, request access »

Biocon Biologics Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Biocon Biologics Canada Toronto, Canada 2023

Biocon Biologics FAQs

  • When was Biocon Biologics founded?

    Biocon Biologics was founded in 1978.

  • Where is Biocon Biologics headquartered?

    Biocon Biologics is headquartered in Bengaluru, India.

  • What is the size of Biocon Biologics?

    Biocon Biologics has 9,500 total employees.

  • What industry is Biocon Biologics in?

    Biocon Biologics’s primary industry is Drug Discovery.

  • Is Biocon Biologics a private or public company?

    Biocon Biologics is a Private company.

  • What is Biocon Biologics’s current revenue?

    The current revenue for Biocon Biologics is .

  • How much funding has Biocon Biologics raised over time?

    Biocon Biologics has raised $3.6B.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process